MANKIND:NSE
Mankind Pharma Ltd
₹2,347.60
arrow_upward
+0.54%(+12.60) 1H
15 Okt, 3:30:00 PTG GMT+5:30 · INR
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk MANKIND...
Buka
₹2,325.60
Tinggi
₹2,365.00
Rendah
₹2,321.10
Permodalan Pasaran
970.28B
Purata volum
488.47K
Volum
645.49K
Nisbah H/P
47.50
tgi 52 mgu
₹2,642.00
rdh 52 mgu
₹1,909.70
EPS
₹49.42
Bilangan pekerja
20K
Buka
₹2,325.60
Tinggi
₹2,365.00
Rendah
₹2,321.10
Permodalan Pasaran
970.28B
Purata volum
488.47K
Volum
645.49K
Nisbah H/P
47.50
tgi 52 mgu
₹2,642.00
rdh 52 mgu
₹1,909.70
EPS
₹49.42
Bilangan pekerja
20K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Astro Awani
·
8 jam lalu
S&P 500: Wall Street market update | 15 October 2026
Invezz
·
2 hari lalu
Dow Jones dibuka 190 mata lebih tinggi, pelabur memerhati pendapatan bank dan inflasi
Invezz
·
2 hari lalu
Dow naik 198 mata, saham AS bercampur menjelang keputusan pendapatan
Invezz
·
1 hari lalu
Dow ditutup 170 mata lebih rendah ketika penjualan saham cip berterusan
Profil
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
Perihal Mankind Pharma Ltd
CEORajeev Juneja | Sheetal Arora
Pekerja20.5K
Diasaskan1991
Ibu pejabat-
Sektor-
Laman webmankindpharma.com